Search Results for: FGFR1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
PDP1 pyruvate dehydrogenase phosphatase catalytic subunit 1
  • Regulation of pyruvate dehydrogenase (PDH) complex
  • Pyruvate dehydrogenase complex deficiency; X-linked Leigh syndrome
PKM pyruvate kinase M1/2
  • Neutrophil degranulation
  • Pyruvic acid
  • L-Phospholactate
  • 2-Phosphoglycolic Acid
  • 6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one
  • 1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine
  • 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine
  • Copper
  • Artenimol
RTN3 reticulon 3
  • Synaptic adhesion-like molecules
SLA Src like adaptor
  • Negative regulation of FLT3
ERBB3 erb-b2 receptor tyrosine kinase 3
  • Tucatinib
  • Lethal congenital contractural syndrome (LCCS)
  • Type I diabetes mellitus
FGF17 fibroblast growth factor 17
FGF5 fibroblast growth factor 5
FGF8 fibroblast growth factor 8
  • Hypogonadotropic hypogonadism; Kallmann syndrome (KAL)
HULC hepatocellular carcinoma up-regulated long non-coding RNA
MFHAS1 malignant fibrous histiocytoma amplified sequence 1
RTN1 reticulon 1
SH3BP2 SH3 domain binding protein 2
  • Cherubism
TNK2 tyrosine kinase non receptor 2
  • ATP
  • Debromohymenialdisine
  • Entrectinib
  • Fostamatinib
TNS2 tensin 2

Page 4 out of 4 pages